To study the role of the thymus in the cellular pathogenesis of myasthenia gravis (MG) we transplanted thymus tissue fragments from MG thymuses beneath the kidney capsule of severe combined immunodeficiency (SCID) mice. Immunocytochemical studies documented that the human thymus tissues are accepted as long-term grafts in the host SCID mice, with human lymphocytes, thymic stroma, and thymic myoid cells demonstrable in transplanted thymus for at least 15 weeks after transplantation. Human anti-acetylcholine receptor antibodies became detectable 1 to 2 weeks after transplantation, and in most chimeras the titers increased over at least 11 weeks to reach levels typically found in severe human MG. Human Ig deposits were detected at skeletal muscle end-plates, demonstrating that the human (auto)antibodies bound to murine acetylcholine receptor. In contrast, transfers of dissociated thymus cells only lead to a transient increase of anti-acetylcholine receptor antibodies. Our data prove that myasthenia gravis thymus is able to induce and maintain autoantibody production in immunodeprived host animals, and that this tissue contains all cellular components required for autoantibody production. Transplantation of solid thymus tissue seems to transfer an autoimmune microenvironment, which will allow direct studies ofthe mechanism of autosensitization inside the thymus. (J. Clin. Invest. 1992. 90:245-250.)
Introduction
Several lines of evidence suggest that the thymus is profoundly involved in the pathogenesis of myasthenia gravis (MG).' More than 70% of MG patients have a thymus with lymphofollicular hyperplasia, and at least 10% have thymic epithelial neoplasia ( 1, 2) . Patients with recent onset of disease and with hyperplastic thymic changes benefit best from thymectomy (3) . In addition to these clinical observations, strong experimental evidence implies the thymus as the primary site of a pathogenic autoimmune response against the neuromuscular acetylcholine receptor (AchR). Thymic myogenic precursor cells are inducible to differentiate in vitro into AchR-expressing myotubes (4) (5) (6) (7) . In fact, AchR is expressed on thymic "myoid cells" (8) , rare muscle-like, HLA-DR-negative cells concentrated at the cortico-medullary junction and in the thymic medulla (9, 10) . In MG, but not in the normal thymus, HLA-DR-positive dendritic cells were found in close proximity to myoid cells (8) (9) (10) . The MG thymus also contains AchR-specific B lymphocytes and plasma cells, that spontaneously produce anti-AchR antibodies (Abs) in vitro (1 1-13). Finally, AchR-specific T lymphocytes can be readily isolated from thymus tissue of most MG patients investigated ( 14, 15) . Hence, in principle, all the cellular elements required for the initiation ofa myasthenogenic autoimmune reaction, i.e., antigen, antigen-presenting cells, autoreactive T and B cells, are present in the MG thymus. The details ofthe complex interactions between these elements remain, however, largely obscure.
We implanted thymus tissue of MG patients into severe combined immunodeficient (SCID) mice that lack a functional immune system ( 16) and hence tolerate xenografts ( 17, 18) . We demonstrate that intact MG thymus tissue engrafted in SCID mice contains all elements necessary to produce and sustain high titers of AChR-specific human auto-Abs.
Methods
Patients. All patients had the typical clinical and electrophysiological signs ofgeneralized MG and elevated anti-AchR serum Abs. Therapeutic thymectomy was performed at the Department of Surgery, Martha Maria Hospital, Munich, Germany; the Department ofSurgery, Grosshadern Medical Center, Gross-hadern, Munich; and the Department of Pediatric Surgery, Kinderkrankenhaus an der Bult, Hannover, Germany. All MG thymuses used for transplantation showed histological lymphofollicular hyperplasia. Control thymuses were obtained from patients undergoing corrective heart surgery (Professor Sebening, German Heart Center, Munich, Germany heat-inactivated serum from AB+ donors, and 5% heat-inactivated horse serum. Subsequently, mAbs were added at the optimal concentration in the same solution for 30 min. After extensive washing with PBS the fluorochrome-labeled secondary Ab was added. The sections were finally mounted in a glycerol-based mounting medium containing 1 mg/mlp-phenylenediamine. The preparations were examined in a Zeiss photomicroscope Photo Ill®.
For staining of muscle tissue, the sections were first blocked with a solution containing PBS, ph 7.2, and BSA 2%, and goat anti-human IgG was then added in the same solution. Subsequently, the rhodamine-labeled secondary Ab and FITC-labeled a-BGT were added together in PBS, ph 7.2, containing 2% BSA and 2% mouse serum.
Detection ofhuman anti-AchR Abs. Abs against human AchR were measured with a radioimmunoprecipitation assay (23) . Briefly, human AchR was labeled with 1251-a-BGT and incubated with appropriate serum dilutions. Ab were precipitated with anti-human IgG, and the concentration ofanti-AchR Abs was calculated from the amount of radioactivity precipitated. Human and mouse IgM and IgG levels were measured using a two-site ELISA. The plates were read at OD 405 using a Titertek MultiskanO (Flow Laboratories, Meckenheim, Germany). Ig standards were obtained from Dianova (ChromPure').
The assay was sensitive to an Ig concentration of 10 ng/ml. Mice were considered leaky if murine Ig concentration was > 50 ng/ml and were excluded from experiments. However, when mice became leaky after transplantation they were (Fig. 1 A) , the graft can be clearly distinguished from the surrounding kidney without evidence of an inflammatory reaction. Two weeks after transplantation the borders of the grafts were usually organized with evidence of neovascularization. Complementary structures of thymic cortex and thymic medulla were both present in the graft (Fig. 1, B Fig. 2 were positive for HLA-DR (Fig. 2 C) . Some ofthe epithelial cells outside the germinal center also stained with HLA-DR. Among the cells inside the germinal center were many CD22-positive B cells located preferentially at the margin ofthe follicle. CD4+ T cells were also present at this site (not shown).
We searched for thymic myoid cells using an antidesmin Ab. Thymic myoid cells were sparsely distributed in some transplants. These desmin-positive cells were HLA-DR-negative and did not stain with mAb 35 that binds the a-subunit of human AchR (not shown).
Human anti-AchR Abs are detectable in the serum oftransplanted SCID mice. Fig. 3 , A-D, shows the time kinetics ofAb titers against human AchR after i.p. injection of 1 X 108 thymocytes (Fig. 3, A and C) and after transplantation ofpieces of MG thymus (Fig. 3, B and D) into SCID mice. (Fig. 3, A and B) represents thymus from two patients with low anti-AchR Ab titers (4.5 nmol/liter) and the lower panel (Fig.  3, C and D) a thymus obtained from a patient with a high preoperative anti-AchR Ab titer (32 nmol/liter). In the mice grafted with thymic cells or tissue from the patient with low anti-AchR Ab titer, anti-AchR Abs were barely detectable after transfer of thymocyte suspensions (Fig. 3 A) , but rose markedly after transplantation of intact thymic fragments (Fig. 3  B) . In contrast, in mice grafted with thymic cells or tissue from the patient with high anti-AchR Ab titer, relatively high concentrations of anti-AchR Abs could be detected both in the mice that had received thymocyte suspensions (Fig. 3 C) and in the mice that had received intact thymic microenvironment (Fig. 3 D) . The peak levels of Ab titers were similar in both groups (Fig. 3, C and D) . Because the mice injected with thymocyte suspensions received 100 times as many cells as did the mice transplanted with intact thymus, the intact thymus was 100 times more effective than the transfer of dissociated thymocyte suspensions. Further, the time course ofAb production differed between the two groups in that the Ab response appeared more slowly in the animals engrafted with thymic tissue (Fig. 3 D) . In the mice injected with thymocyte suspension, titers began to fall after 3-7 weeks (Fig. 3 C) (Fig. 3 D) . The long-term fate of engrafted thymus will be examined in future experiments. Only a small fraction ( -0.1 to 0.01%) of the human IgG detected in mouse serum was directed against AchR, indicating that only some ofthe B cells present in the transplanted thymus were specific for AchR. Two to four weeks after transplantation the titers of total human IgG in the mice ranged from 2 to 13 ,Ug/ml.
In the SCID mice engrafted with normal human thymus, human IgG could also be detected, but the titers were generally lower (0.25-3 ,g/ml between weeks 3 and 6). Abs against the AchR were never detected in these mice. Human anti-AchR Abs bind to mouse muscle endplates. We next asked whether human anti-AchR Abs could be detected at neuromuscular junctions of transplanted mice. Gluteal muscle oftransplanted mice was double-stained for human IgG (red), and for the a-subunit of AchR (green). In mice transplanted with myasthenic thymus human Ig could be detected at neuromuscular junctions. Note that the pattern of staining for IgG is very similar to the pattern of staining for AchR (Fig. 4) . In control mice transplanted with normal human thymus, muscle endplates could be demonstrated with FITC-a-BGT, but no binding ofhuman IgG was detected. The intensity offluorescence staining for a-BGT was lower in SCID mice with circulating anti-AchR auto-Abs than in control SCID mice transplanted with normal thymus.
Discussion
The pathogenic role ofanti-AChR auto-Abs was established by direct transfer into appropriate recipient mice (25) . The cellular mechanisms leading to the generation of pathogenic autoAbs have been less readily accessible to study. ( 19) , owing to their inability to rearrange lymphocyte receptor genes (26) . Indeed, several reports indicated that dissociated human immune cells survived for considerable periods in SCID recipient mice ( 18) , and that these cells continued to produce their (auto-)Ab for some time (27, 28) .
In a first set of experiments we injected single cell suspensions of thymocytes obtained from MG (or normal) thymus i.p. into SCID mice. Although human Ig and anti-AchR autoAbs could be detected within a few days after cell transfer, the transfer of suspensions of dissociated thymocytes was at least 100 times less effective than the transplantion of intact thymic microenvironment. Further, human lymphocytes could not be detected in murine lymphoid organs, indicating that they could not efficiently recirculate and home in the xenogeneic organism.
Like in other studies ( 17, 29) , transplantation of human T cells within their autochthonous stromal context drastically improved their survival in SCID hosts. We assume that the cytokines and cell adhesion molecules required for immune cell survival were lacking in the single cell transfer situations, but were provided by transplanting intact lymphoid tissue containing (auto)immune lymphoid cells embedded in autochthonous stroma.
The human thymus grafts had profound effects on the recipient SCID mice. Although we took care to exclude leaky mice from the graft recipients, 30% of the xenotransplanted mice developed mouse Ig levels> 50 ng/ml during the course ofthe experiment. The percentage of leaky mice was < 10% in untransplanted SCID mice, 10-20% in mice transplanted with normal thymus, and 70% in mice transplanted with MG thymus. The increased proportion of leaky mice in the transplantation groups could reflect infections acquired in the course of the multiple surgical manipulations. Alternatively, lymphokines produced by human lymphocytes may have induced the immature murine B cells to produce immunoglobulin. In the MG thymus groups the increased proportion ofleakiness could be related to the unique properties ofthe thymic microenvironment in MG (1, (8) (9) (10) .
Leakiness did not interfere with the success ofgraft take. All engrafted kidneys contained human tissue at the time of autopsy as shown by the immunocytochemical demonstration of cytokeratin and human HLA-ABC. This is in some contrast to data reported by Barry et al. (24) . Using a similar experimental protocol, but postnatal normal human thymus, they showed that only 73% of engrafted thymuses could be detected in the kidney at the time ofautopsy. Apart from technical differences, the high proportion of "peripheralized" lymphoid tissue typically seen in MG thymuses (8) could account for the discrepancy.
The MG thymus fragments continued to produce human anti-AchR auto-Ab for at least three months. The serum titers reached levels typically seen in human MG patients. It is not surprising, however, that the level of human Ig exceeds the level of human anti-AChR auto-Ab. It is known that MG thymuses not only contain B cells producing anti-AChR Abs, but seem to attract any B cells activated in the course of a recent peripheral Ab response ( 12) .
We found a very notable decoration ofneuromuscular endplates with human immunoglobulin. This proves that the human auto-Ab cross-reacted with murine AchR. The fact that the transplanted mice did not show clinical myasthenia is not too surprising, considering the amazing resistance of mice to manipulations of endplate AChR (30) . However, in future studies the potential pathogenic effects of the anti-AchR Abs could be analyzed by quantitating endplate specific a-BGT binding, determining C3 and C9 localization, and by examination of the endplate ultrastructure. Further, it will be interesting to see whether at any time endplates are invaded by macrophages, as happens in some species after immunization with AchR (2).
This new MG thymus/SCID mouse transplantation model described here provides firm support for the key role of the thymus in spontaneous human MG (4, 5, 14) . It should be useful to study the cellular interplay between antigen-producing, -presenting, and -recognizing thymus cells. We anticipate that it will also help to develop strategies for immune intervention at early (afferent) stages of the pathogenesis.
